Recombinant erythropoietin biosimilar - EleaAlternative Names: Human recombinant erythropoietin - Elea; Pronivel; r-hu-EPO - Elea
Latest Information Update: 05 Aug 2015
At a glance
- Originator Elea
- Class Antianaemics; Erythropoietins
- Mechanism of Action Erythropoiesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 15 Mar 2016 Biomarkers information updated